Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-7-27
pubmed:abstractText
Severity of fibrosis after injury is determined by the nature of the injury and host genetic susceptibility. Metabolism of collagen, the major component of fibrotic lesions, is, in part, regulated by integrins. Using a model of glomerular injury by adriamycin, which induces reactive oxygen species (ROS) production, we demonstrated that integrin alpha1-null mice develop more severe glomerulosclerosis than wild-type mice. Moreover, primary alpha1-null mesangial cells produce more ROS both at baseline and after adriamycin treatment. Increased ROS synthesis leads to decreased cell proliferation and increased glomerular collagen IV accumulation that is reversed by antioxidants both in vivo and in vitro. Thus, we have identified integrin alpha1beta1 as a modulator of glomerulosclerosis. In addition, we showed a novel pathway where integrin alpha1beta1 modulates ROS production, which in turn controls collagen turnover and ultimately fibrosis. Because integrin alpha1beta1 is expressed in many cell types this may represent a generalized mechanism of controlling matrix accumulation, which has implications for numerous diseases characterized by fibrosis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10213868, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10222005, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10587612, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10681423, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10719231, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10727440, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-10805967, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11012915, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11073824, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11409888, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11447218, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11641239, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-11891185, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-12000729, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-12297042, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-12368200, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-12507718, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-12594056, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-1638527, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-1692924, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7001707, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7538261, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7600259, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7752581, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7775196, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-7919151, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-8626034, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-8885242, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-8929541, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-9355070, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-9578071, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-9679154, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-9885280, http://linkedlifedata.com/resource/pubmed/commentcorrection/15277235-9891015
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
617-30
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury.
pubmed:affiliation
Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University, Medical Center North, B3109, 1161 21st Ave., Nashville, TN 37212, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't